Follow
Donghui Li
Donghui Li
Scientist, Tessera Therapeutics, PhD from Johns Hopkins School of Medicine
Verified email at tesseratx.com
Title
Cited by
Cited by
Year
Affinity proteomics reveals human host factors implicated in discrete stages of LINE-1 retrotransposition
MS Taylor, J LaCava, P Mita, KR Molloy, CRL Huang, D Li, EM Adney, ...
Cell 155 (5), 1034-1048, 2013
2302013
BRCA1 and S phase DNA repair pathways restrict LINE-1 retrotransposition in human cells
P Mita, X Sun, D Fenyö, DJ Kahler, D Li, N Agmon, A Wudzinska, ...
Nature structural & molecular biology 27 (2), 179-191, 2020
772020
Retrotransposon Ty1 RNA contains a 5′-terminal long-range pseudoknot required for efficient reverse transcription
Q Huang, KJ Purzycka, S Lusvarghi, D Li, SFJ LeGrice, JD Boeke
Rna 19 (3), 320-332, 2013
352013
Fluorescence ImmunoPrecipitation (FLIP): a novel assay for high-throughput IP
P Mita, T Lhakhang, D Li, DJ Eichinger, D Fenyo, JD Boeke
Biological Procedures Online 18, 1-14, 2016
82016
Application of counter-selectable marker PIGA in engineering designer deletion cell lines and characterization of CRISPR deletion efficiency
D Li, X Sun, F Yu, MA Perle, D Araten, JD Boeke
Nucleic acids research 49 (5), 2642-2654, 2021
72021
BRCA1 Mediated Homologous Recombination and S Phase DNA Repair Pathways Restrict LINE-1 Retrotransposition in Human Cells
X Sun, P Mita, DJ Kahler, D Li, A Wudzinska, C Yun, JS Bader, D Fenyö, ...
bioRxiv, 701458, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–6